Pioneering 3D Human Tissues for Drug Discovery

Jan 06 | 2025

Organovo Announces Appointment of Norman Staskey as Chief Financial Officer

Read More »

Nov 20 | 2024

Organovo Presents Clinical Data of FXR314 in Phase 2 MASH in an Oral Presentation at The Liver Meeting

Read More »

Nov 13 | 2024

Organovo to Present Clinical Data of FXR314 in Phase 2 MASH in an Oral Presentation at The Liver Meeting Sponsored by the American Association for the Study of Liver Diseases

Read More »